CRYOPORT, INC. Depreciation
CRYOPORT, INC. (CYRX) reported Depreciation of $12.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-05
- CRYOPORT, INC. depreciation for the quarter ending 2014-03-31 was $44.38K, a 24.74% decline year-over-year.
- CRYOPORT, INC. depreciation for the quarter ending 2013-12-31 was $51.48K, a 18.53% decline year-over-year.
- CRYOPORT, INC. depreciation for the quarter ending 2013-09-30 was $61.82K, a 33.31% decline year-over-year.
- CRYOPORT, INC. depreciation for the quarter ending 2013-06-30 was $61.72K, a 7.66% decline year-over-year.
- CRYOPORT, INC. depreciation for fiscal 2025 was $12.50M, a 13.64% increase from fiscal 2024.
- CRYOPORT, INC. depreciation for fiscal 2024 was $11.00M, a 17.02% increase from fiscal 2023.
- CRYOPORT, INC. depreciation for fiscal 2023 was $9.40M, a 22.08% increase from fiscal 2022.
- CRYOPORT, INC. depreciation for fiscal 2022 was $7.70M, a 32.76% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $12.50M 10-K · filed 2026-03-05 | ||||
| 2024-12-31 | $11.00M 10-K · filed 2026-03-05 | $13.60M 10-K · filed 2025-03-07 | |||
| 2023-12-31 | $9.40M 10-K · filed 2026-03-05 | $11.20M 10-K · filed 2024-03-13 | |||
| 2022-12-31 | $7.70M 10-K · filed 2025-03-07 | ||||
| 2021-12-31 | $5.80M 10-K · filed 2024-03-13 | ||||
| 2020-12-31 | $3.20M 10-K · filed 2023-02-28 | ||||
| 2019-12-31 | $2.10M 10-K · filed 2022-02-28 | ||||
| 2018-12-31 | $857.90K 10-K · filed 2020-03-10 | ||||
| 2017-12-31 | $664.80K 10-K · filed 2019-03-13 | ||||
| 2016-12-31 | $292.70K 10-K · filed 2018-03-08 | ||||
| 2016-03-31 | $209.10K 10-KT · filed 2017-03-13 | ||||
| 2015-03-31 | $154.70K 10-K · filed 2016-06-28 | ||||
| 2014-03-31 | $44.38K derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-19 | $95.86K derived: sum of 2 quarters · filed 2015-05-19 | $157.68K derived: sum of 3 quarters · filed 2015-05-19 | $219.40K 10-K · filed 2015-05-19 | |
| 2013-12-31 | $51.48K 10-Q · filed 2014-02-13 | $113.30K derived: sum of 2 quarters · filed 2014-02-13 | $175.02K 10-Q · filed 2014-02-13 | $233.99K derived: sum of 4 quarters · filed 2014-06-25 | |
| 2013-09-30 | $61.82K 10-Q · filed 2013-11-18 | $123.54K 10-Q · filed 2013-11-18 | $182.51K derived: sum of 3 quarters · filed 2014-06-25 | $245.70K derived: sum of 4 quarters · filed 2014-06-25 | |
| 2013-06-30 | $61.72K 10-Q · filed 2013-08-14 | $120.69K derived: sum of 2 quarters · filed 2014-06-25 | $183.87K derived: sum of 3 quarters · filed 2014-06-25 | $276.58K derived: sum of 4 quarters · filed 2014-06-25 | |
| 2013-03-31 | $58.97K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-25 | $122.15K derived: sum of 2 quarters · filed 2014-06-25 | $214.86K derived: sum of 3 quarters · filed 2014-06-25 | $281.70K 10-K · filed 2014-06-25 | $281.70K 10-K · filed 2013-06-25 |
| 2012-12-31 | $63.18K 10-Q · filed 2014-02-13 | $155.89K derived: sum of 2 quarters · filed 2014-02-13 | $222.73K 10-Q · filed 2014-02-13 | $287.58K derived: sum of 4 quarters · filed 2014-02-13 | |
| 2012-09-30 | $92.70K 10-Q · filed 2013-11-18 | $159.55K 10-Q · filed 2013-11-18 | $224.39K derived: sum of 3 quarters · filed 2013-11-18 | $286.96K derived: sum of 4 quarters · filed 2013-11-18 | |
| 2012-06-30 | $66.84K 10-Q · filed 2013-08-14 | $131.69K derived: sum of 2 quarters · filed 2013-08-14 | $194.25K derived: sum of 3 quarters · filed 2013-08-14 | $253.51K derived: sum of 4 quarters · filed 2013-08-14 | |
| 2012-03-31 | $64.85K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | $127.41K derived: sum of 2 quarters · filed 2013-06-25 | $186.67K derived: sum of 3 quarters · filed 2013-06-25 | $241.84K 10-K · filed 2013-06-25 | |
| 2011-12-31 | $62.57K 10-Q · filed 2013-02-14 | $121.82K derived: sum of 2 quarters · filed 2013-02-14 | $176.99K 10-Q · filed 2013-02-14 | ||
| 2011-09-30 | $59.25K 10-Q · filed 2012-11-09 | $114.42K 10-Q · filed 2012-11-09 | |||
| 2011-06-30 | $55.17K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |